A small molecule drug LM22A-4 led to increased AKT phosphorylation and partially rescued locomotor activity, insulin intolerance, and HDL levels, while delaying the onset of obesity in SMS mice. Here, AKT1 is linked to obesity due to melanocortin 4 receptor deficiency.